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Bullous pemphigoid antigen 2 (BP180; COL17A1) collagen gene mutations typically result in nonlethal junctional
epidermolysis bullosa. We have identiﬁed a patient, who had phenotypic features of mainly epidermolysis bullosa
simplex and evidence for both intraepidermal and junctional blister formation. Mutation analysis disclosed
compound heterozygous mutations in the COL17A1 gene, leading to deletion of Ile-18 to Asn-407 from the
intracellular domain of BP180, BP180D18–407. To gain insight into the mechanisms underlying the phenotype, we
have investigated the functional consequences of this truncation in BP180. The results demonstrate that: (1) in
cultured keratinocytes of the patient, the assembly of hemidesmosomes, and their linkage with intermediate
ﬁlaments are impaired; (2) BP180D18–407 is not capable of binding to the hemidesmosomal components BP230,
plectin, and the b4 subunit of the a6b4 integrin in yeast two-hybrid assays; (3) BP180D18–407 is recruited into
hemidesmosome-like structures in both normal and BP180-deﬁcient transfected keratinocytes when ectopically
expressed, suggesting that the extracellular domain of BP180D18–407 determines its topogenic fate; and, ﬁnally (4)
the proteolytic shedding of the extracellular domain of BP180D18–407 is not impaired in transfected COS-7 cells.
Collectively, the data demonstrate that the truncation of the intracellular domain of BP180 impairs the organization
of hemidesmosomes, affecting both the mechanical stability of basal keratinocytes and dermoepidermal cohesion.
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Epidermolysis bullosa (EB) comprises a large group of
mechanobullous diseases characterized by fragility of the
skin and mucosae (reviewed in Eady, 2001; Uitto and
Pulkkinen, 2001). These disorders are caused by patho-
genic mutations in genes encoding constituents of the
hemidesmosomes and related structures, that critically
promote strong stromal–epithelial cohesion (reviewed in
Borradori and Sonnenberg, 1999). Three major variants of
EB have been defined based on the level of tissue
separation along the cutaneous basement membrane. First,
EB simplex shows tissue separation within the cytoplasm of
basal keratinocytes. It is typically due to mutations in genes
encoding either keratin 5, keratin 14, or plectin. Secondly, in
junctional EB, separation occurs within the basement
membrane at the level of the lamina lucida; this group of
EB results from mutations in either of at least six different
genes coding for the two transmembrane hemidesmosomal
components bullous pemphigoid (BP) 180 (also called
collagen XVII or BPAG2) and the a6b4 integrin or
laminin-5. Thirdly, in dystrophic EB, a disease caused by
type VII collagen gene mutations, blistering takes places
below the basement membrane within the upper papillary
dermis (reviewed in Pulkkinen and Uitto, 1998; Bruckner-
Tuderman, 1999; Irvine and McLean, 1999; Fine et al,
2000).
BP180, originally identified as the autoantigen of BP
(Labib et al, 1986; Diaz et al, 1990; Giudice et al, 1992;
Hopkinson et al, 1992), is a type II transmembrane protein
with a large collagenous extracellular domain (ECD)
(Giudice et al, 1992; Scha¨cke et al, 1998; Nykvist et al,
2001). Pathogenic mutations in the BP180 (COL17A1) gene
are usually, but not always associated with nonlethal
junctional EB variants. Most of the implicated mutations
are premature termination codons resulting in non-sense-
mediated mRNA decay with no or poor BP180 expression
at the protein level (McGrath et al, 1995; Chavanas et al,
1997; Darling et al, 1997).
Recently, we described an unusual patient with pheno-
typic features of mainly EB simplex. Genetic analysis
revealed compound heterozygous mutations in the BP180
gene leading to a large in frame deletion from residue 18 to
407 from the cytoplasmatic domain of BP180 (Fig 1). Blister
formation occurred either at the level of lamina lucida or
Abbreviations: AD, transcription-activation domain; BD,
DNA-binding domain; BP230, bullous pemphigoid antigen
1; BP180, bullous pemphigoid antigen 2; EB, epidermolysis
bullosa; ECD, extracellular domain; IF, intermediate fila-
ments; nt, nucleotides
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within the basal keratinocytes. Ultrastructurally, the attach-
ment of keratin filaments to the hemidesmosomal plaque
appeared to be impaired (Huber et al, 2002). As there is no
evidence for a direct linkage of BP180 with epidermal
keratins, it is likely that the severing of the keratin bundles is
indirect. Recent studies found that BP180 binds to BP230
and plectin, two cytoplasmic hemidesmosomal compo-
nents of the plakin family of cytolinkers (Aho and Uitto,
1999; Koster et al, 2003). The C-terminal tail domain of
these two proteins is able to bind to intermediate filament
(IF) proteins, whereas their N-terminal head domain is
associated with the cytoplasmic domain of the b4 subunit of
the a6b4 integrin and to BP180 (Hopkinson and Jones,
2000; Favre et al, 2001; Fontao et al, 2003; Koster et al,
2003). Hence, BP230 and plectin act as linkers, connecting
the IF network with BP180 and the a6b4 integrin at the basal
cell side (Borradori and Sonnenberg, 1999).
To explain better the EB simplex phenotype in our
patient, we assessed the functional consequences of the
large deletion within BP180D18–407 and carried out morpho-
logic, cell biologic, and yeast assays. The results indicate
that in the presence of BP180D18–407 the molecular
organization of hemidesmosome is severely altered.
Although its potential to be recruited into hemidesmo-
some-like structures in keratinocytes and its shedding from
the cell surface are unaffected, BP180D18–407 has lost the
ability to bind to BP230, plectin, and the b4 integrin subunit.
Results
Electron microscopic analysis of cultured primary
keratinocytes To assess the impact of the large deletion
from the cytoplasmic domain of BP180 on the formation of
hemidesmosomes, electron microscopy studies were per-
formed on cultured primary keratinocytes derived from our
EB patient expressing BP180D18–407 (BP180D18–407 kerati-
nocytes) and from a healthy volunteer (NHK), respectively.
BP180D18–407 keratinocytes exhibited only rare membrane-
associated electron-dense structures at sites of cell-
substrate contact (Fig 2A). Their appearance was rudimen-
tary, as there was no obvious inner and outer cytoplasmic
plate, and they did not associate with keratin filament
bundles. By contrast, NHK displayed normal looking
hemidesmosome with an outer and inner plate that was
frequently linked with keratin filament bundles (Fig 2B).
Distribution of hemidesmosomal components in cul-
tured primary keratinocytes We next examined by con-
focal immunofluorescence microscopy the expression and
Figure1
Schematic diagram of BP180, BP230,
plectin, the b4 integrin subunit, and
the various deletion mutants utilized.
IC, intracellular domain; EC, Extracellu-
lar domain; TM, Transmembrane do-
main; IFBD, IF-binding domain; ABD,
Actin-binding domain.
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localization of hemidesmosomal components in primary
keratinocytes. Staining using the MoAb 1D1 demonstrated
that in BP180D18–407 keratinocytes BP180D18–407 localized in
discrete clusters and patches, the staining pattern of which
was typical for hemidesmosome-like structures (Schaap-
veld et al, 1998) (Fig 3C). As expected, no staining was
detected with the MoAb 1A8c directed against the
cytoplasmic domain of BP180 (not shown). Furthermore,
in BP180D18–407 keratinocytes, BP230 was not co-distrib-
uted with either b4 (not shown) or BP180 in hemidesmo-
some-like structures but remained diffusely distributed over
the cytoplasm of these cells (Fig 3D). Plectin was no longer
exclusively concentrated in hemidesmosome-like struc-
tures together with the a6b4 integrin but was also found
diffusely distributed in the cytoplasm (Fig 4D). In contrast, in
NHK BP180, BP230, plectin, and a6b4 integrin were
normally concentrated at the basal sites of the cells in a
pattern typical for hemidesmosome-like structures (Figs 3
and 4).
BP180D18–407 is recruited into hemidesmosome-like
structures upon ectopic expression in normal and
BP180-deﬁcient keratinocytes As sequences within the
cytoplasmic domain of BP180 regulate its subcellular
localization (Borradori et al, 1997), it was unexpected to
find BP180D18–407 concentrated in hemidesmosome-like
structures. Therefore, we tested the topogenic fate of
BP180D18–407 upon its expression in 804G cells and a
Figure4
Immunolocalization of the b4 integrin subunit and plectin in
cultured BP180D18–407 keratinocytes by confocal laser microscopy.
Normal human keratinocytes (A,B) and BP180D18–407 keratinocytes
(C,D) grown on glass coverslip were double stained with a guinea pig
anti-plectin antibody (B,D) and the MoAb 3E1 recognizing the b4
integrin subunit (A,C). Plectin is colocalized with b4 in large patches
typical of hemidesmosome-like structures in normal human keratino-
cytes. In BP180D18–407 keratinocytes, clusters of plectin are found in
only about 10% of cells and show reduced colocalization with b4. A
predominant diffuse cytoplasmic staining is observed for plectin. Scale
bar¼15 mm.
Figure 2
Electron microscopic examination of the basal regions of cultured
BP180D18–407 keratinocytes and normal human keratinocytes. A few
rudimentary membrane-associated electron-dense plaques at sites of
cell-substrate contact (arrowheads) are observed in cultured BP180D18–
407 keratinocytes. Keratin filament bundles (CK) are not significantly
connected to these junctional complexes (A). In normal human
keratinocytes (B) the morphology of hemidesmosomes (arrowheads)
appear normal with a sub-basal dense plate and an inner plate
connected to keratin filaments. Cells were grown on coverslips coated
with conditioned medium from 804G cells enriched in laminin-5 as
described in the Materials and Methods. Scale bar¼0.2 mm.
Figure 3
Immunolocalization of BP180 and BP230 in cultured BP180D18–407
keratinocytes by confocal laser microscopy. Normal human kerati-
nocytes (A,B) and BP180D18–407 keratinocytes (C,D) cultured on glass
coverslips were double stained with the MoAb 1D1 directed against
BP180 (A,C) and the human MoAb 5E recognizing BP230 (B,D).
Confocal optical sections made at the basal side of the cells shows a
clear colocalization of BP180 and BP230 in large patches typical for
hemidesmosome-like structures in normal human keratinocytes. In
BP180D18–407 keratinocytes, BP180 is clustered at the basal aspect of
the cell, whereas BP230 remains diffusely in the cytoplasm. Scale
bar¼ 15 mm.
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previously described PAJEB/b4 keratinocyte cell line (Sterk
et al, 2000). Both wild-type and BP180D18–407 recombinant
proteins were found co-distributed with the a6b4 integrin in
hemidesmosome-like structures when ectopically ex-
pressed in these cell lines (not shown). To assess whether
the subcellular distribution of BP180D18–407 depends on its
ability to form heterotrimers with endogenous BP180, we
carried out transfection studies using an immortalized
BP180-deficient cell line (Koster et al, 2003). In few of the
transfected cells, BP180D18–407 was found colocalized with
a6b4 in hemidesmosome-like structures (Fig 5). Overall,
these findings indicate that the topogenic fate of BP180D18–407
most likely depends on its interaction with an extracellular
matrix protein present on the glass coverslips and/or the
ability of its ECD to bind to the a6 subunit (Hopkinson et al,
1998).
Deletion of residues 18 to 407 in BP180 impaired its
association with the b4 integrin subunit, BP230 and
plectin The cytoplasmic domain of BP180 contains binding
sites for BP230, plectin, and the b4 subunit (Borradori et al,
1997; Aho and Uitto, 1998; Schaapveld et al, 1998;
Hopkinson and Jones, 2000; Koster et al, 2003). Therefore,
we tested whether deletion of residues 18 to 407 from the
cytoplasmic domain of BP180 impairs its ability to interact
with b4, plectin, and BP230 by using yeast two-hybrid
assays. For this purpose, PJ69 yeast was cotransformed
with a pAS2-1 plasmid construct encoding residues 1 to
400 of BP180 as GAL4-BD fusion protein, GAL4-BD-
BP1801–400 together with a pACT2 plasmid construct
encoding deletion mutants of the b4 subunit, plectin,
or BP230, all fused to the GAL4-AD (Figs 1 and 6).
Cotransformed yeasts were selected and tested for
protein–protein interactions using the b-galactosidase as-
says. The results demonstrate that GAL4-BD-BP1801–400
encoding residues 1 to 400 of the cytoplasmic domain of
BP180 strongly bound to the GAL-AD-b41115–1666 construct
encoding a region of the b4 cytoplasmic domain encom-
passing both pairs of type III fibronectin repeats. The same
GAL4-BD-BP1801–400 also strongly interacted with GAL4-
AD-BP2301–887, GAL4-AD-PLC1–1398, and GAL4-AD-
PLC173–1398, encoding the N-terminal parts of BP230 and
plectin, respectively. In BP230, residues 1 to 887 encom-
passing repeat NN to W of its plakin domain were sufficient
to mediate strong binding to BP180. Furthermore, both the
constructs GAL4-AD-PLC1–1398 and GAL4-AD-PLC173–1398,
lacking half the actin-binding domain, bound to BP180 to a
similar extent. In contrast, GAL4-BD-BP180D18–407 contain-
ing the cytoplasmic deletion showed no binding activity
towards GAL4-AD constructs of plectin, BP230, and b4 (Fig
6). We could not test a construct encoding the cytoplasmic
domain of BP180, the transmembrane and part of the ECD,
GAL4-BD-BP1801–520, as transformed yeast had a ten-
dency for transactivation. Finally, we tested the ability of
BP180 to bind to K5/K14 keratins in yeast three-hybrid
assays. We found that a large portion of the cytoplasmic
domain of BP180, GAL4-BD-BP1801–400, bound to mono-
meric K5 and K14 and the K5/K14 heterodimer (not shown).
BP180D18–407 is normally post-translationally proces-
sed To re-evaluate in detail the impact of the truncation
on shedding of the ECD of BP180 from the cell surface
(Scha¨cke et al, 1998; Franzke et al, 2002), we utilized
transiently transfected COS-7 cells encoding wild-type
BP180 or BP180D18–407. As depicted in Fig 7, Western blot
analysis of extracts from COS-7 cells transfected with
cDNA for wild-type BP180 identifies two proteins with an
electrophoretic mobility of approximately 180 and 120 kDa,
respectively. Whereas the former corresponds to the
unprocessed form of BP180, the latter represents the shed
Figure6
Assessment of the binding ability of BP180 recombinant proteins
fused to GAL4-BD with distinct regions of BP230, of plectin, and of
the cytoplasmic domain of b4 fused to GAL4-AD in yeast two-
hybrid assays. The PJ69-4A yeast strain was cotransformed with
pAS2-1 plasmid encoding either residues 1 to 400 (bars 1–4) or
residues 1 to 520 with the D18-407 deletion (bars 5–8) of BP180 as
GAL4-BD fusion proteins, and pACT2 plasmids encoding residues 1 to
887 of BP230 (bars 1 and 5), residues 1115 to 1666 of the b4 integrin
subunit (bars 2 and 6), residues 1 to 1398 of plectin (bars 3 and 7) or
residues 173 to 1398 of plectin (bars 4 and 8) as GAL4-AD fusion
proteins. The b-galactosidase activity of yeast transformants was
quantified in liquid assays using O-nitrophenyl b-D-galactopyranoside
as a substrate as described in Materials and Methods. In these assays
the b-galactosidase activity is proportional to the strength of the
interaction.
Figure 5
BP180D18–407 becomes localized into hemidesmosome-like struc-
tures upon its expression in BP180-deficient keratinocytes. BP180-
deficient keratinocytes were transiently transfected with cDNA encod-
ing wild-type BP180 (A–C) and BP180D18–407 (D–F), that were FLAG-
tagged at their N-terminus. Forty-eight hours after transfection cells
were double stained with an anti-a6 integrin subunit antibody (B,E) and
the anti-FLAG antibody (A,D) and viewed under confocal laser
microscope. Both BP180 and BP180D18–407 show a colocalization with
the a6 integrin subunit in hemidesmosome-like structures. Overlay of
red and green channel is shown in C and F. Scale bar¼25 mm.
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ECD (Scha¨cke et al, 1998). This 120 kDa fragment was also
identified in the culture medium of COS-7 cells. When
extracts of COS-7 cells transfected with cDNA encoding
BP180D18–407 were assayed, reactivity with a 130 kDa
polypeptide corresponding to unprocessed BP180D18–407
and a 120 kDa polypeptide were identified. The latter was
also detected in the culture medium. Hence, the deletion
from the cytoplasmic domain of BP180 has no deleterious
effect on the shedding of its ECD.
Discussion
We investigated the impact of the large deletion from the
cytoplasmic domain of BP180D18–407 on the formation and
organization of hemidesmosome. Our results demonstrate
that: (1) in the presence of BP180D18–407 the assembly of
hemidesmosomes and their linkage with the IF cytoskeleton
are severely impaired; (2) BP180D18–407 is recruited into
hemidesmosome-like structures when ectopically ex-
pressed in both normal and BP180-deficient keratinocytes,
although it has lost the ability to bind to the hemidesmo-
somal components BP230, plectin, and the b4 subunit of
the a6b4 integrin; and finally (3) the shedding of the ECD of
BP180D18–407 is unaffected by the deletion.
The ultrastructural studies provide evidence that primary
cultured BP180D18–407 keratinocytes exhibit few and rudi-
mentary hemidesmosomes, which appear to be poorly
connected with keratin IF bundles. These observations
indicate, in analogy to what is observed in vivo in the skin of
the EB patient (Huber et al, 2002), that BP180 is necessary
in vitro for the formation of hemidesmosomes and for their
linkage with the keratin IF network. This idea is further
substantiated by our immunofluorescence microscopy
studies, which demonstrated that the molecular organiza-
tion of hemidesmosome-like structures in BP180D18–407
keratinocytes is disturbed in vitro. These observations
are in line with results of previous studies utilizing
immortalized keratinocyte cell lines, which completely
lacked BP180 expression (Borradori et al, 1998; Koster
et al, 2003).
Immunofluorescence microscopy analyses of cultured
BP180D18–407 keratinocytes (this study) and of the patient’s
skin (Huber et al, 2002) disclosed that the distribution
pattern of BP180D18–407 was not significantly impaired.
Therefore, the behavior of BP180D18–407 was further
evaluated in transfection studies. The findings confirm that
BP180D18–407 has the potential to become recruited into
hemidesmosome-like structures upon ectopic expression.
These results are at apparent variance with previous reports
indicating that the cytoplasmic domain of BP180 is required
for its localization in hemidesmosomes (Borradori et al,
1997, 1998). A plausible explanation for these discrepancies
is that, in contrast to these latter studies, in our case
BP180D18–407 has an intact ECD, which may bind to an as
yet undefined extracellular ligand deposited on the cover-
slip, or, alternatively, to the ECD of the a6 subunit of the
a6b4 integrin, as previously reported (Hopkinson et al,
1998). Finally, BP180D18–407 potentially form heterotrimers
with endogenous wild-type BP180. Nevertheless, our
results, utilizing BP180-deficient keratinocytes, demon-
strate that BP180D18–407 can be recruited into hemidesmo-
some-like structures even in the absence of endogenous
BP180. These and previous observations (Borradori et al,
1997, 1998) indicate that the localization of BP180 to the
basal side of keratinocytes occurs by two independent
mechanisms involving interactions with either cytoplasmic
components of hemidesmosomes or, alternatively, with
extracellular matrix proteins and/or the ECD of the a6
subunit.
The results in yeast demonstrate that BP180D18–407 has
lost the capacity to associate with the N-terminal portions of
both plectin and BP230 as well as with the b4 cytoplasmic
domain of the a6b4 integrin, a transmembrane protein
playing a key role in the formation of hemidesmosomes and
their regulation (reviewed in Borradori and Sonnenberg,
1999). These findings confirm a recent study showing that
the cytoplasmic tail of BP180 is crucial for its association
with BP230 and plectin via their Y domain (Koster et al,
2003). Specifically, the stretch of residues 145 to 230 in the
cytoplasmic domain of BP180 was critical for binding to
BP230. It should be noted that, in contrast to BP230, plectin
was found, although to a reduced extent, in hemidesmo-
some-like structures of cultured BP180D18–407 keratino-
cytes. Whereas the presence of both BP180 and b4 is
critical for the localization of BP230 into hemidesmosomes
(this study; Schaapveld et al, 1998; Koster et al, 2003),
plectin can be recruited into hemidesmosomes even in the
Figure 7
The shedding of the ECD of BP180D18–407 is unaffected in
transfected COS-7 cells. COS-7 cells were transfected with cDNA
encoding wild-type BP180 (lanes 1 and 2) and BP180D18–407 (lanes 3
and 4). Cell extracts (lanes 1 and 3) and cell culture media (lanes 2 and
4) were immunoblotted with a rabbit anti-serum directed against the
NC16A domain of BP180. The shed ectodomain of 120 kDa could be
detected in media (lanes 2 and 4) and cell extracts (lanes 1 and 3)
obtained from transfected COS-7 cells expressing either wild-type
BP180 or BP180D18–407. Furthermore, proteins of 180 kDa (lane 1) and
130 kDa (lane 3) corresponding to unprocessed full-length BP180 and
BP180D18–407, respectively, were detected in extracts from transfected
cells.
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absence of BP180, by means of a direct association with
the b4 subunit (Niessen et al, 1997; Schaapveld et al, 1998;
Koster et al, 2003). Finally, although we found that the
cytoplasmic domain of BP180 interacts with monomeric K5
and K14 and the K5/K14 heterodimers in yeast, these
results may not be biologically relevant, as: (1) in transfec-
tion studies, BP180 mutant proteins encompassing the
intracellular domain do not become colocalized with the
keratin network (Borradori et al, 1997, 1998; Koster et al,
2003); (2), in recent yeast assays the binding ability of
certain BP230 and desmoplakin mutant proteins with
monomeric keratins, such as K5, K14, and K18, could not
be confirmed by biochemical and cell biologic approaches,
and appeared to be an artifact related to the truncation
procedures (Fontao et al, 2003). Collectively, these data
demonstrate that the deletion in the cytoplasmic domain of
BP180D18–407 has two major consequences explaining the
phenotype of the patient: (1) it disturbs the molecular
composition and stability of hemidesmosomes, resulting in
defective dermo-epidermal cohesion, and (2) it affects the
tethering of the keratin IF network to the basal cell
membrane, making the basal keratinocytes fragile with cell
rupturing and development of an EB simplex phenotype. In
this regard, gene-targeted elimination of BP230 and plectin
in mice has demonstrated the critical role of these proteins
for the linkage of the keratin IF network to hemidesmo-
somes (Guo et al, 1995; Andra¨ et al, 1997; Steinbock and
Wiche, 1999). Furthermore, in EB simplex patients carrying
pathogenic mutations in the plectin-gene, the connection of
the IF network with hemidesmosomes is also affected
(Smith et al, 1996).
Finally, we assessed whether the truncation in BP180D18–
407 alters its proteolytic processing and the shedding of its
ECD. Shedding has been shown to depend on a disintegrin
and metalloprotease domain (ADAM) proteases and is
thought to affect keratinocyte adhesion, differentiation,
and migration (Franzke et al, 2002). Here we show that
the 120 kDa ECD of BP180D18–407, similarly to what was
observed in keratinocytes (Huber et al, 2002), is properly
shedded in transfected COS-7 cells. Based on these
observations, it is likely that in our patient dermo-epidermal
fragility and blistering result from disturbed assembly of
hemidesmosomes rather than from the altered incorpora-
tion of BP180 and its shed ECD into the cutaneous
basement membrane.
In conclusion, our findings demonstrate that the trunca-
tion of the cytoplasmic domain in BP180D18–407 has a
profound impact on the assembly of hemidesmosomes,
impairing both the mechanical stability of basal keratino-
cytes and dermo-epidermal cohesion. This study indicates
that without the cytoplasmic domain of BP180, BP230,
plectin, and a6b4 are ineffective at connecting the IF
network to hemidesmosomes and, thus, to extracellular
matrix proteins.
Materials and Methods
EB patient The BP180D18–407 keratinocytes were derived from a
previously described EB patient as reported (Huber et al, 2002).
Mutational analysis disclosed one mutation (R1226X) leading to a
premature termination codon accompanied by a non-sense
mediated mRNA decay, whereas the other resulted in skipping of
exons 3 to 15 in COL17A1 gene and in synthesis of a truncated 130
kDa BP180 protein.
cDNA constructs cDNA constructs encoding BP1801–520 and
BP180D18–407 were generated using primers that added appro-
priate stop codons along with restriction sites allowing subcloning
in a polymerase chain reaction with proof-reading Pfu polymerase
(Promega, Madison, WI). cDNA fragments covering different parts
of plectin were obtained by reverse transcription–polymerase chain
reaction using a human keratinocyte cDNA library, as template,
with a superscript one-step reverse transcription–polymerase
chain reaction system with platinum Taq according to the
manufacturer’s instruction (Invitrogen, Carlsbad, CA). Correctness
of all constructs was verified by DNA sequence analysis. Plasmids
containing cDNA encoding full-length FLAG-tagged BP180 and
BP1801–400, BP2301–887, and b41115–1667 have been previously
described (Borradori et al, 1997; Koster et al, 2003) (Fig 1).
Cell culture and transfection The immortalized PA-JEB/b4 (Sterk
et al, 2000) and the BP180-deficient (Koster et al, 2003)
keratinocyte cell lines, primary normal human keratinocytes
(NHK) and BP180D18–407 keratinocytes were cultured in Keratino-
cyte-SFM medium (Invitrogen). NHK and BP180D18–407 keratino-
cytes were isolated as described (Limat and Noser, 1986; Huber
et al, 2002). Keratinocytes differentiation was induced by incuba-
tion for 48 h in HAMF12/Dulbecco minimal Eagle’s medium (1:3)
(Invitrogen) (Schaapveld et al, 1998). 804G and COS-7 cells were
grown in Dulbecco minimal Eagle’s medium (Invitrogen) supple-
mented with 10% (v/v) bovine fetal bovine serum, 100 U per mL
penicillin, and 100 U per mL streptomycin.
For immunofluorescence staining, cells were plated on glass
coverslip coated with laminin-5 enriched medium produced by
804G cells (Hormia et al, 1995). Cells were grown up to 50 to 60%
confluency, then made to differentiate (see above) for 48 h before
processing. For transfection, cells were plated at 40 to 60%
confluency on glass coverslips in six-well tissue culture plates.
Keratinocytes were transiently transfected with Lipofectamine
2000 (Invitrogen) according to the manufacturer’s procedure.
COS-7 cells were transfected using the DEAE-dextran method.
Two days after, transfected cells were processed for confocal
microscopy (Favre et al, 2001) and viewed under a Zeiss LSM410
confocal inverted laser scanning microscope.
Antibodies The following immuno-reagents were used: rabbit
anti-a6 integrin subunit anti-serum (Delwel et al, 1993); mouse
monoclonal antibody (MoAb) anti-Flag M2 (Sigma); mouse MoAb
3E1 anti-b4 integrin subunit (Hessle et al, 1984); mouse MoAb
1A8c and 1D1, that recognize the cytoplasmic domain and the
ECD of BP180, respectively (Nishizawa et al, 1993), rabbit anti-
serum directed against the NC16A domain of BP180 (Schumann
et al, 2000); mouse MoAb 121 anti-plectin (Hieda et al, 1992); a
guinea pig anti-plectin antibody (Progen, Heidelburg, Germany),
the human MoAb 5E anti-BP230 (Hashimoto et al, 1993), Alexa-
488 conjugated-goat anti-rabbit IgG (Molecular Probes), Alexa-568
conjugated-goat anti-mouse and anti-guinea pig IgG (Molecular
Probes, Leiden, The Netherlands); Alexa-568 conjugated-goat
anti-human IgG (Molecular Probes); the mouse MoAb and rabbit
anti-serum anti-Gal4-AD or Gal4-BD (Santa Cruz, Santa Cruz, CA),
peroxidase-coupled anti-rabbit IgG or anti-mouse IgG (Bio-Rad,
Hercules, CA).
Electron microscopy BP180D18–407 keratinocytes and NHK were
plated on themanox coverslips coated with conditioned medium
from 804G cells enriched in laminin-5 to ensure optimal culture
conditions (Hormia et al, 1995) and grown to confluency in
Keratinocyte-SFM medium. Cell monolayers were made to
differentiate for 72 h, then fixed for 2 h in 2% glutaraldehyde (v/v)
in phosphate-buffered saline at reverse transcription and pro-
cessed for electron microscopy. Ultrathin sections were examined
with CM10 Philips electron microscope at 80 kV.
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Ectodomain shedding of BP180 For the shedding experiments,
COS-7 cells were transiently transfected with a cDNA construct
encoding wild type or BP180D18–407 as described earlier (Borodori
et al, 1997). Medium from the COS-7 cells was collected 48 h after
transfection, cooled, centrifuged to remove cellular debris,
and supplemented with 1 mM Pefablock (Merck, Glattburg,
Switzerland) and 1 mM N-ethylamide (Sigma, St. Louis MO). The
proteins from 1 mL of medium or 100 mL of cell extract were
concentrated by precipitation with 70% ethanol and separated
using sodium dodecyl sulfate–polyacrylamide gel electrophoresis
with 6–22% polyacrylamide gradient gel.
Western blot analysis Protein extracts were prepared in sodium
dodecyl sulfate sample buffer, heated for 5 min at 951C, and
analyzed by sodium dodecyl sulfate–polyacrylamide gel electro-
phoresis followed by western blotting as described (Favre et al,
2001).
Yeast two- and three-hybrid analyses The Saccharomyces
cerevisiae strain PJ69-4A, which contains the genetic markers
trp1-901, leu2-3112 ura3-52, his3-200, gal4D, gal80 D, LYS2::-
GAL1-HIS3, GAL2-ADE2, met2::GAL7-lacZ (James et al, 1996)
was used for all assays. It contains three tightly regulated reporter
genes, HIS3, ADE2, and Lac-Z each driven by a different promoter
under the control of GAL4 transcriptional factor. Cells were
cotransformed with two defined constructs in pAS2-1, pACT2
(Clontech, Palo Alto, CA), according to Clontech’s procedure.
Double transformants were selected on agar synthetic complete
(SC) medium lacking leucine and tryptophan (SC-LW). For each
transformation, eight colonies were arrayed in 96 well microtiter
plates and then transferred on to agar SC-LW (positive control),
SC-LW without adenine, and SC-LW without histidine and
supplemented with 2 mM 3-amino 1,2,3-triazole. After a 5 d
incubation at 301C, three independent colonies were tested for
protein–protein interactions using the semi quantitative b-galacto-
sidase assay as described (James et al, 1996). Yeast three-hybrid
assays were carried out as reported in detail elsewhere (Fontao
et al, 2003). Trans-activation controls were performed for each
construct with the opposite vector without insert.
To ascertain that the transformed yeast expressed the various
recombinant proteins, cell extracts were prepared by the trichlor-
oacetic acid method (Clontech Protocol Handbook) and subjected
to immunoblotting with antibodies directed to the GAL4-AD or
GAL4-BD. Protein bands of the expected size were observed (not
shown).
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